High Point Advisor Group LLC Alnylam Pharmaceuticals, Inc. Put Options Transaction History
High Point Advisor Group LLC
- $2.05 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALNY
# of Institutions
867Shares Held
115MCall Options Held
559KPut Options Held
673K-
Capital World Investors Los Angeles, CA16.4MShares$7.46 Billion1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$6.16 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.33 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.22MShares$3.28 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY4.54MShares$2.06 Billion0.14% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $55.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...